UPDATE : Friday, July 10, 2020
상단여백
Ministry OKs Dongkook's P3 trial into benign prostatic hyperplasia treatment by Lee Han-soo 2020-07-10 16:54
Court rejects Medytox's request not to revoke license of Medytoxin by Lee Han-soo 2020-07-10 14:59
'Xolair’s reimbursement will change treatment paradigm for asthma patients' by Lee Han-soo 2020-07-09 18:11
Drugmakers appeal limited insurance benefit for dementia drug choline alfoscerate by Kim Chan-hyuk 2020-07-09 12:52
‘Hypertension drug Opsumit enhances right ventricle function’ by Shim Hyun-tai 2020-07-08 16:59
라인
Crystal Genomics confirms safety of super-bacteria antibiotic candidate by Lee Han-soo 2020-07-08 16:58
‘Study results on MSD’s Keytruda very disappointing’ by Kim Yun-mi 2020-07-07 16:43
ITC ruling gives Medytox upper hand in BTX strain dispute by Lee Han-soo 2020-07-07 11:47
Daewoong to conduct P1 trial of Covid-19 treatment in Indonesia by Lee Han-soo 2020-07-06 16:52
Regulator OKs Janssen's multiple myeloma treatment by Lee Han-soo 2020-07-06 15:48
라인
Experts showed mixed preferences between 2 diabetes treatments by Kim Yun-mi 2020-07-06 14:20
[News Focus] Who will win BTX strain dispute – Daewoong or Medytox? by Kim Chan-hyuk 2020-07-06 11:50
Crystal Genomics to start P2 trial of Covid-19 treatment by Lee Han-soo 2020-07-02 18:07
Boryung finds cancer drug has antiviral effect on Covid-19 by Shim Hyun-tai 2020-07-02 18:07
Heliximith unveiled how HX109 inhibits prostate hyperplasia by Lee Han-soo 2020-07-02 15:03
라인
MSD Korea reshuffles personnel before spinoff of Organon by Kim Yun-mi 2020-07-02 13:44
Novartis’ asthma drug gets insurance benefit by Shim Hyun-tai 2020-07-01 20:05
Takeda Korea completes takeover of Shire Korea by Lee Han-soo 2020-07-01 17:39
Hanmi to export dyslipidemia drug to Mexico via MSD by Shim Hyun-tai 2020-07-01 14:19
Hanmi's short bowel syndrome treatment wins rare pediatric disease status by Lee Han-soo 2020-06-30 17:38
-12345678910-
WUH’s affiliate firm exports mobile CT for Covid-19 to IranWUH’s affiliate firm exports mobile CT for Covid-19 to Iran
여백
Most viewed
여백
Opinion
[Reporter's Notebook] Drugmakers introduce creative PR formats amid Covid-19
[Reporter's Notebook] Drugmakers introduce creative PR formats amid Covid-19
[Reporter's Notebook] Korean firms found something missing in ‘virtual’ ASCO 2020
[Reporter's Notebook] Korean firms found something missing in ‘virtual’ ASCO 2020
[Column] 'New normal' of healthcare in post-corona era
[Column] 'New normal' of healthcare in post-corona era
여백
Back to Top